ERAS vs EWTX: stock comparison and AI forecast
Erasca, Inc. (ERAS) and Edgewise Therapeutics, Inc. (EWTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ERAS Erasca, Inc.
- Price
- $13.27 +27.6% · 6M
- Market Cap
- $4.64B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
EWTX Edgewise Therapeutics, Inc.
- Price
- $38.87 +9.2% · 6M
- Market Cap
- $4.22B
- P/E Ratio
- 4.6x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ERAS and EWTX have similar market capitalizations ($4.64B and $4.22B).
- Over the last six months ERAS returned +27.6% and EWTX +9.2%.
- ERAS carries 0.20 times debt per unit of equity, against 0.09 times for EWTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ERAS | EWTX |
|---|---|---|
| Market Cap | $4.64B | $4.22B |
| P/E Ratio | – | 4.62x |
| P/B Ratio | 12.83x | 2.59x |
| EPS | $-0.46 | $8.41 |
| Book Value/Share | $1.03 | $15.03 |
| FCF/Share | $-0.28 | $-1.86 |
Profitability & Margins
| Metric | ERAS | EWTX |
|---|---|---|
| ROE | – | 61.8% |
| ROA | – | 56.7% |
| ROIC | -75.4% | -13.3% |
Financial Health
| Metric | ERAS | EWTX |
|---|---|---|
| Current Ratio | 8.29x | 12.30x |
| D/E Ratio | 0.20x | 0.09x |
| Financial Leverage | 1.20x | 1.09x |
| Working Capital | $245M | $1.63B |
Cash Flow
| Metric | ERAS | EWTX |
|---|---|---|
| Operating Cash Flow | -$98M | -$202M |
| Free Cash Flow | -$98M | -$202M |
| Capital Spending | -$60K | -$380K |
Income Statement
| Metric | ERAS | EWTX |
|---|---|---|
| Operating Income | -$303M | -$218M |
| Net Income | – | $1.01B |
| R&D Expense | $109M | $165M |
Dividend & Shareholder Information
| Metric | ERAS | EWTX |
|---|---|---|
| Shares Outstanding | 350M | 109M |
ERAS vs EWTX: stock comparison and AI forecast
Which is bigger, ERAS or EWTX?
ERAS and EWTX have similar market capitalizations ($4.64B and $4.22B).
Which stock performed better over the last six months, ERAS or EWTX?
Over the last six months ERAS returned +27.6% and EWTX +9.2%.
Which one does Intratio's AI model rank higher, ERAS or EWTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.